[English] 日本語
Yorodumi- PDB-9bop: A broadly-neutralizing antibody against Ebolavirus glycoprotein t... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9bop | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | A broadly-neutralizing antibody against Ebolavirus glycoprotein that can potentiate the breadth and neutralization potency of other anti-glycoprotein antibodies | ||||||||||||||||||||||||
Components |
| ||||||||||||||||||||||||
Keywords | VIRAL PROTEIN/IMMUNE SYSTEM / Ebola / IgG / neutralization / complex / glycoprotein / VIRAL PROTEIN-IMMUNE SYSTEM complex / ebolavirus | ||||||||||||||||||||||||
| Function / homology | Function and homology informationsymbiont-mediated-mediated suppression of host tetherin activity / clathrin-dependent endocytosis of virus by host cell / entry receptor-mediated virion attachment to host cell / symbiont-mediated suppression of host innate immune response / fusion of virus membrane with host endosome membrane / viral envelope / lipid binding / host cell plasma membrane / virion membrane / extracellular region Similarity search - Function | ||||||||||||||||||||||||
| Biological species | ![]() Ebolavirus | ||||||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3 Å | ||||||||||||||||||||||||
Authors | Donnellan, F.R. / Rayaprolu, V. / Rijal, P. / O'Dowd, V. / Parvate, A. / Callaway, H. / Hariharan, C. / Parekh, D. / Hui, S. / Shaffer, K. ...Donnellan, F.R. / Rayaprolu, V. / Rijal, P. / O'Dowd, V. / Parvate, A. / Callaway, H. / Hariharan, C. / Parekh, D. / Hui, S. / Shaffer, K. / Hastie, K. / Shimanski, L. / Muller-Krauter, H. / Stecker, T. / Balaram, A. / Halfmann, P. / Saphire, E.O. / Lightwood, D.J. / Townsend, A.R. / Draper, S.J. | ||||||||||||||||||||||||
| Funding support | United Kingdom, 1items
| ||||||||||||||||||||||||
Citation | Journal: Npj Viruses / Year: 2026Title: A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies. Authors: Francesca R Donnellan / Vamseedhar Rayaprolu / Pramila Rijal / Victoria O'Dowd / Amar Parvate / Heather Callaway / Chitra Hariharan / Dipti Parekh / Sean Hui / Kelly C L Shaffer / Ruben Diaz ...Authors: Francesca R Donnellan / Vamseedhar Rayaprolu / Pramila Rijal / Victoria O'Dowd / Amar Parvate / Heather Callaway / Chitra Hariharan / Dipti Parekh / Sean Hui / Kelly C L Shaffer / Ruben Diaz Avalos / Kathryn M Hastie / Lisa Schimanski / Helena Müller-Kräuter / Thomas Strecker / Ariane Balaram / Peter Halfmann / Erica Ollmann Saphire / Daniel J Lightwood / Alain R Townsend / Simon J Draper / ![]() Abstract: Ebolavirus disease (EVD) is caused by multiple species of orthoebolavirus. Monoclonal antibodies (mAbs) against the virus glycoprotein (GP) are the only class of therapeutic approved for treatment of ...Ebolavirus disease (EVD) is caused by multiple species of orthoebolavirus. Monoclonal antibodies (mAbs) against the virus glycoprotein (GP) are the only class of therapeutic approved for treatment of EVD caused by Orthoebolavirus zairense (Ebola virus, EBOV). Therefore, mAbs targeting multiple orthoebolavirus species may represent the next generation of EVD therapeutics. Broadly reactive anti-GP mAbs were produced; among these, mAbs 11886 and 11883 were broadly neutralizing in vitro. A 3.0 Å cryo-electron microscopy structure of EBOV GP bound to both mAbs shows that 11886 binds a novel epitope bridging the glycan cap (GC), 3 pocket and GP2 N-terminus, whereas 11883 binds the receptor binding region (RBR) and GC. In vitro, 11886 synergized with a range of mAbs with epitope specificities spanning the RBR/GC, including 11883. Notably, 11886 increased the breadth of neutralization by partner mAbs against different orthoebolavirus species. These data provide a strategic route to design improved mAb-based next-generation EVD therapeutics. | ||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9bop.cif.gz | 432.9 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9bop.ent.gz | 346.2 KB | Display | PDB format |
| PDBx/mmJSON format | 9bop.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/bo/9bop ftp://data.pdbj.org/pub/pdb/validation_reports/bo/9bop | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 44747MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Protein , 2 types, 5 molecules ACEMO
| #1: Protein | Mass: 15837.846 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human)#3: Protein | Mass: 15854.976 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human) |
|---|
-Virion spike glycoprotein ... , 2 types, 6 molecules STUVWX
| #5: Protein | Mass: 31256.092 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Ebolavirus / Gene: GP / Variant: Mayinga / Production host: ![]() #6: Protein | Mass: 15206.248 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Ebolavirus / Gene: GP / Variant: Mayinga / Production host: ![]() |
|---|
-Antibody , 2 types, 5 molecules BDFNP
| #2: Antibody | Mass: 14970.940 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human)#4: Antibody | Mass: 15134.112 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human) |
|---|
-Sugars , 2 types, 12 molecules 
| #7: Polysaccharide | Source method: isolated from a genetically manipulated source #8: Sugar | ChemComp-NAG / |
|---|
-Details
| Has ligand of interest | Y |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component |
| ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight |
| ||||||||||||||||||||||||||||||
| Source (natural) |
| ||||||||||||||||||||||||||||||
| Source (recombinant) |
| ||||||||||||||||||||||||||||||
| Buffer solution | pH: 7.5 | ||||||||||||||||||||||||||||||
| Buffer component |
| ||||||||||||||||||||||||||||||
| Specimen | Conc.: 1.9 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||||||||||||||||||||
| Specimen support | Grid material: COPPER / Grid mesh size: 300 divisions/in. / Grid type: C-flat-2/1 | ||||||||||||||||||||||||||||||
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 100 % / Chamber temperature: 278 K |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: FEI TITAN KRIOS / Details: Total dose of 50e/A2 |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 75000 X / Nominal defocus max: 2500 nm / Nominal defocus min: 1000 nm / Cs: 2.7 mm / Alignment procedure: COMA FREE |
| Specimen holder | Cryogen: NITROGEN / Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
| Image recording | Electron dose: 50 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Num. of grids imaged: 1 / Num. of real images: 9552 |
| EM imaging optics | Energyfilter name: GIF Bioquantum |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| Symmetry | Point symmetry: C1 (asymmetric) | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 66500 / Symmetry type: POINT | ||||||||||||||||||||||||
| Atomic model building | Protocol: AB INITIO MODEL | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




Ebolavirus
United Kingdom, 1items
Citation


PDBj




Homo sapiens (human)

FIELD EMISSION GUN